JPH0581566B2 - - Google Patents
Info
- Publication number
- JPH0581566B2 JPH0581566B2 JP60177355A JP17735585A JPH0581566B2 JP H0581566 B2 JPH0581566 B2 JP H0581566B2 JP 60177355 A JP60177355 A JP 60177355A JP 17735585 A JP17735585 A JP 17735585A JP H0581566 B2 JPH0581566 B2 JP H0581566B2
- Authority
- JP
- Japan
- Prior art keywords
- glucosamine
- skin
- cells
- whitening
- test
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000002537 cosmetic Substances 0.000 claims description 14
- 150000002301 glucosamine derivatives Chemical class 0.000 claims description 9
- 239000000126 substance Substances 0.000 claims description 8
- 125000002252 acyl group Chemical group 0.000 claims description 5
- 239000004480 active ingredient Substances 0.000 claims description 2
- 150000002336 glycosamine derivatives Chemical class 0.000 claims 1
- 230000002087 whitening effect Effects 0.000 description 23
- 210000003491 skin Anatomy 0.000 description 19
- 210000004694 pigment cell Anatomy 0.000 description 16
- 210000004027 cell Anatomy 0.000 description 14
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 13
- 230000000694 effects Effects 0.000 description 10
- 229960001911 glucosamine hydrochloride Drugs 0.000 description 9
- CBOJBBMQJBVCMW-BTVCFUMJSA-N (2r,3r,4s,5r)-2-amino-3,4,5,6-tetrahydroxyhexanal;hydrochloride Chemical compound Cl.O=C[C@H](N)[C@@H](O)[C@H](O)[C@H](O)CO CBOJBBMQJBVCMW-BTVCFUMJSA-N 0.000 description 8
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 8
- -1 hydrochloride Tetra-O-propanoyl-glucosamine hydrochloride N-octanoyl-glucosamine N-acetyl-1,3,4,6-tetra-O- Propionylglucosamine N-acetyl-1,3,4,6-tetra-O- Butyrylglucosamine Chemical compound 0.000 description 8
- 229960002442 glucosamine Drugs 0.000 description 7
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 6
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 6
- 229960004705 kojic acid Drugs 0.000 description 6
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- 206010040829 Skin discolouration Diseases 0.000 description 4
- 235000010323 ascorbic acid Nutrition 0.000 description 4
- 229940117916 cinnamic aldehyde Drugs 0.000 description 4
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 4
- 230000008099 melanin synthesis Effects 0.000 description 4
- 201000001441 melanoma Diseases 0.000 description 4
- 239000012488 sample solution Substances 0.000 description 4
- 206010014970 Ephelides Diseases 0.000 description 3
- 206010015150 Erythema Diseases 0.000 description 3
- 108010024636 Glutathione Proteins 0.000 description 3
- 208000003351 Melanosis Diseases 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 231100000321 erythema Toxicity 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 229960003180 glutathione Drugs 0.000 description 3
- 230000000684 melanotic effect Effects 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 150000000996 L-ascorbic acids Chemical class 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 206010047642 Vitiligo Diseases 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
- 229960001231 choline Drugs 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 231100001083 no cytotoxicity Toxicity 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- 206010033733 Papule Diseases 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- ZRAWPYYLRZSVEU-GNMOMJPPSA-N [(2r,3s,4r,5r)-3,4,6-triacetyloxy-5-aminooxan-2-yl]methyl acetate Chemical compound CC(=O)OC[C@H]1OC(OC(C)=O)[C@H](N)[C@@H](OC(C)=O)[C@@H]1OC(C)=O ZRAWPYYLRZSVEU-GNMOMJPPSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 238000010218 electron microscopic analysis Methods 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- DOPGJHMBFNGSTK-NKLQQJLKSA-N n-[(3r,4r,5s,6r)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]octanamide Chemical compound CCCCCCCC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O DOPGJHMBFNGSTK-NKLQQJLKSA-N 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229940057847 polyethylene glycol 600 Drugs 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 229940100611 topical cream Drugs 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
Description
〔産業上の利用分野〕
本発明は色白化粧料に関するものである。
〔従来の技術〕
一般に皮膚に対して日光からの紫外線が照射さ
れると皮膚内の色素細胞メラノサイトにおいてメ
ラニンが著しく生成して皮膚が黒色化する傾向が
ある。このような日焼けによつて生じる皮膚の黒
化の防止、また、メラニン色素の沈着によるシ
ミ、ソバカスを除去することを目的として化粧料
に配合される物質としては、アスコルビン酸類
(特開昭59−65007)、過酸化水素、グルタチオン
(特開昭57−134410)、コロイド硫黄、ハイドロキ
ノン(特開昭59−157009)、コウジ酸(特公昭60
−7961)、桂皮アルデヒド(特開昭58−55414)等
が知られているが、アスコルビン酸類は湿性製品
の如き水分を多く含む系においては酸化されやす
く不安定であり、変色、変臭の原因となりがちで
ある。過酸化水素については過酸化物という特性
上、安全性、保存面、安定性面から充分なものと
は言い難い。グルタチオンやコロイド硫酸は異臭
を放つため色白化粧料へ使用することは避けられ
ている。ハイドロキノンは、細胞毒性が強く安全
性面から充分なものとは言い難い。またコウジ酸
および桂皮アルデヒドは、少量では皮膚の黒化を
防止する効果が小さく色白化粧料への使用におい
て充分なものとは言い難い。近年、カニ殻等から
精製されるグルコサミン塩酸塩がメラニン産生色
素細胞(melanotic型黒色腫細胞)の培養系で、
メラニン生産能の不可逆的な喪失を生じさせるこ
となく色素細胞を白色化させることが見い出され
た(芋川玄爾、三島豊:培養黒色腫細胞内
glucosamine誘導メラニン生成抑制の電顕的解
析.Proc.Jap.Soc.Invest.Derm.,5:103−104,
1980)。グルコサミン塩酸塩の色素細胞に対する
上述の効果は色白化粧料として人体に投与した場
合、ハイドロキノンのように色素細胞のメラニン
産生能を不可逆的に喪失することがないため白斑
のような皮膚への障害が少ないことを示唆するも
のである。しかしながら、グルコサミン塩酸塩の
色素細胞に対する白色化効果を発現さすためには
高濃度のグルコサミン塩酸塩の存在が必要であ
り、また経皮吸収による生体内取り込みが難しい
ため、そのままでは色白化粧料への利用効果が小
さい。
〔発明が解決しようとする問題点〕
発明者等はかかる現状に鑑み、白色化効果が大
きく、しかもその作用が可逆的であり皮膚に対す
る安全性の高い色白化粧料を提供することを目的
として鋭意研究した結果、グルコサミンのアシル
誘導体が色素細胞に対し色白化効果が著しく強
く、しかもその作用が可逆的であることを見い出
し、本発明を完成するに至つた。
〔問題点を解決するための手段〕
すなわち本発明は、
(1) 式
[Industrial Application Field] The present invention relates to fair skin cosmetics. [Prior Art] Generally, when the skin is irradiated with ultraviolet rays from sunlight, melanin is significantly produced in the pigment cell melanocytes in the skin, and the skin tends to turn black. Ascorbic acids (Japanese Unexamined Patent Application Publication No. 1983-1993) are used as substances in cosmetics for the purpose of preventing skin darkening caused by sunburn and removing spots and freckles caused by melanin pigment deposition. 65007), hydrogen peroxide, glutathione (Japanese Patent Publication No. 57-134410), colloidal sulfur, hydroquinone (Japanese Patent Publication No. 59-157009), kojic acid (Japanese Patent Publication No. 1983-157009),
-7961), cinnamaldehyde (Japanese Patent Application Laid-open No. 58-55414), etc. However, ascorbic acids are easily oxidized and unstable in systems containing a lot of water such as wet products, causing discoloration and odor. This tends to be the case. Due to the characteristics of hydrogen peroxide, it is difficult to say that it is sufficient in terms of safety, storage, and stability. Glutathione and colloidal sulfuric acid give off a strange odor, so their use in fairing cosmetics is avoided. Hydroquinone is highly cytotoxic and cannot be said to be sufficient from a safety standpoint. Furthermore, in small amounts, kojic acid and cinnamaldehyde have a small effect in preventing skin darkening, and cannot be said to be sufficient for use in fair skin cosmetics. In recent years, glucosamine hydrochloride purified from crab shells, etc. has been used in culture systems for melanin-producing pigment cells (melanotic melanoma cells).
It was discovered that pigment cells can be whitened without irreversible loss of melanin production ability (Genji Imokawa, Yutaka Mishima: Intracultured Melanoma Cells)
Electron microscopic analysis of glucosamine-induced suppression of melanin production. Proc.Jap.Soc.Invest.Derm., 5:103-104,
1980). The above-mentioned effect of glucosamine hydrochloride on pigment cells is that when administered to the human body as a skin-lightening cosmetic, unlike hydroquinone, it does not irreversibly lose the melanin production ability of pigment cells, so it does not cause skin damage such as vitiligo. This suggests that there are few. However, in order for glucosamine hydrochloride to exhibit its whitening effect on pigment cells, a high concentration of glucosamine hydrochloride is required, and it is difficult to be absorbed into the body through transdermal absorption, so it cannot be used as is in skin-whitening cosmetics. Usage effect is small. [Problems to be solved by the invention] In view of the current situation, the inventors have worked diligently with the aim of providing a skin-whitening cosmetic that has a large whitening effect, is reversible, and is highly safe for the skin. As a result of research, it was discovered that acyl derivatives of glucosamine have a significantly strong skin whitening effect on pigment cells, and that this effect is reversible, leading to the completion of the present invention. [Means for solving the problem] That is, the present invention solves the following problems: (1) Equation
次に本発明の有効成分であるグルコサミン誘導
体のメラニン産生色素細胞(melanotic型黒色腫
細胞)に対する白色化効果を以下の試験例にて実
証する。
実施例 1
テトラ−O−アセチル−グルコサミン塩酸塩
テトラ−O−プロパノイル−グルコサミン塩酸
塩
N−オクタノイル−グルコサミン
N−アセチル−1,3,4,6−テトラ−O−
プロピオニルグルコサミン
N−アセチル−1,3,4,6−テトラ−O−
ブチリルグルコサミン
N−アセチル−1,3,4,6−テトラ−O−
アセチルグルコサミン
N−アセチル−3,4,6−トリ−O−ブチリ
ルグルコサミン
N−アセチル−3,4,6−トリ−O−プロピ
オニルグルコサミン
N−アセチル−3,4,6−トリ−O−アセチ
ルグルコサミン
N−アセチル−1−プロピオニルグルコサミン
N−ブチリル−1,3,4,6−テトラ−O−
ブチリルグルコサミン
O−β−オクタノイル−グルコサミン酢酸塩
N−オクタデカノイル−グルコサミン
O−β−オクタデカノイル−グルコサミン塩酸
塩
N−モンタノイル−グルコサミン
N−メリシノイル−グルコサミン
N−リノレニル−グルコサミン
N−エルカニル−グルコサミン
N−アセチルグルコサミン
グルコサミン塩酸塩
ハイドロキノン
コウジ酸
アルコルビン酸
試料液の調製
試験物質は、表1−1と表1−2に示す濃度に
なるよう純水に溶解した後、安全ギヤビネツト内
で孔径0.2μmの除菌フイルターで濾過して試料液
とした。
Next, the whitening effect of glucosamine derivatives, which are the active ingredients of the present invention, on melanin-producing pigment cells (melanotic melanoma cells) will be demonstrated in the following test examples. Example 1 Tetra-O-acetyl-glucosamine hydrochloride Tetra-O-propanoyl-glucosamine hydrochloride N-octanoyl-glucosamine N-acetyl-1,3,4,6-tetra-O-
Propionylglucosamine N-acetyl-1,3,4,6-tetra-O-
Butyrylglucosamine N-acetyl-1,3,4,6-tetra-O-
Acetylglucosamine N-acetyl-3,4,6-tri-O-butyrylglucosamine N-acetyl-3,4,6-tri-O-propionylglucosamine N-acetyl-3,4,6-tri-O-acetyl Glucosamine N-acetyl-1-propionylglucosamine N-butyryl-1,3,4,6-tetra-O-
Butyrylglucosamine O-β-octanoyl-glucosamine acetate N-octadecanoyl-glucosamine O-β-octadecanoyl-glucosamine hydrochloride N-montanoyl-glucosamine N-mericinoyl-glucosamine N-linolenyl-glucosamine N-elcanyl-glucosamine N-acetylglucosamine Glucosamine hydrochloride Hydroquinone Kojic acid Alcorbic acid Preparation of sample solution The test substance was dissolved in pure water to the concentration shown in Tables 1-1 and 1-2, and then placed in a safety gear cabinet with a pore size of 0.2 μm. It was filtered with a sterilization filter and used as a sample solution.
【表】【table】
【表】
色素細胞
色素細胞は培養細胞として確立されているB−
16mouse melanotic型黒色腫細胞を用いた。
試験方法
安全キヤビネツト内において、シヤーレ(60mm
直径)に試料液0.1ml,1.5×105個の色素細胞を含
む培養液0.1ml,10%牛胎児血清を含むイーグル
最小栄養培地3.8mlを加え。炭酸ガス培養器にお
いて5%の炭酸ガスを含有する空気下37℃・6日
間培養した。なお、コントロールは試料液のかわ
りに純水を加え培養した。6日間培養した色素細
胞は、培養液を除去しダルベツコリン酸緩衝液で
洗浄した後、0.025%トリプシンを含むダルベツ
コリン酸緩衝液を加え細胞を剥離した。次いで剥
離した色素細胞に培養液4mlを加え懸濁させ細胞
数の測定を行つた後、1000rpm・10分間遠心して
得られた色素細胞の白色化の程度を肉眼により比
較した。
−1 試験結果
表2−1、表2−2および表2−3に結果を示
す。[Table] Pigment cells Pigment cells are B- cells that have been established as cultured cells.
16mouse melanotic melanoma cells were used. Test method In a safety cabinet, a shear plate (60mm
diameter), add 0.1 ml of sample solution, 0.1 ml of culture medium containing 1.5 × 10 5 pigment cells, and 3.8 ml of Eagle's minimal nutrient medium containing 10% fetal bovine serum. The cells were cultured in a carbon dioxide incubator at 37°C for 6 days in air containing 5% carbon dioxide. In addition, as a control, pure water was added and cultured instead of the sample solution. The culture medium was removed from the pigmented cells that had been cultured for 6 days, and the cells were washed with Dulbets' choline buffer, followed by the addition of Dulbets' choline buffer containing 0.025% trypsin to detach the cells. Next, 4 ml of culture solution was added to the detached pigment cells to suspend them, and the number of cells was measured, followed by centrifugation at 1000 rpm for 10 minutes, and the degree of whitening of the pigment cells obtained was visually compared. -1 Test results The results are shown in Table 2-1, Table 2-2 and Table 2-3.
【表】【table】
【表】
※ :白色化度大、+:やや白色化、−:白色化せ
ず
以上の結果より、本発明のグルコサミン誘導体
はグルコサミン塩酸塩より色素細胞に対する白色
化効果が強く、また従来知られているコウジ酸、
アスコルビン酸よりも白色化効果を示すことが認
められた。さらに、ハイドロキノンに比べ細胞毒
性を殆ど示さずに白色化する事が認められた。な
お、炭素数30のアシル基を有するN−メリシノイ
ル−グルコサミンはグルコサミン塩酸塩と同程度
の白色化効果でしかなく、試験に供した炭素数29
以下のアシル基を有するグルコサミン誘導体のい
ずれよりも効果が劣つた。特に炭素数1〜8のア
シル基を有するグルコサミン誘導体がより強い白
色化効果を示した。
試験例 2
試験例1で白色化した細胞について、試験例1
の試験方法に準じ、試験液を加えずに再度培養
し、得られた細胞について白色化の程度を肉眼に
より比較した。
−2 試験結果
表3に結果を示す。[Table] *: High degree of whitening, +: Slightly whitening, -: No whitening From the above results, the glucosamine derivative of the present invention has a stronger whitening effect on pigment cells than glucosamine hydrochloride, and it also shows that the glucosamine derivative of the present invention has a stronger whitening effect on pigment cells than glucosamine hydrochloride. kojic acid,
It was found to have a more whitening effect than ascorbic acid. Furthermore, whitening was observed with almost no cytotoxicity compared to hydroquinone. Note that N-merisinoyl-glucosamine, which has an acyl group with 30 carbon atoms, has a whitening effect comparable to that of glucosamine hydrochloride;
It was less effective than any of the following glucosamine derivatives having an acyl group. In particular, glucosamine derivatives having an acyl group having 1 to 8 carbon atoms showed a stronger whitening effect. Test Example 2 Regarding the whitened cells in Test Example 1, Test Example 1
The cells were cultured again without adding the test solution according to the test method described above, and the degree of whitening of the obtained cells was visually compared. -2 Test results Table 3 shows the results.
【表】
※ :白色化度大、+:やや白色化、−:白色化せ
ず
以上の結果より、本発明のグルコサミン誘導体
は色素細胞のメラニン生成を著しく抑制するが、
その効果が可逆的であり細胞の生育には悪影響を
与えないことが認められた。これに対し従来知ら
れているハイドロキノンは、試験液を加えない再
培養においても色素細胞は白色化したままであ
り、また細胞の生育も著しく不良であつた。
試験例 3
試験例1の試験物質を2つ以上混合して、試験
例1の試験方法に準して培養し、得られた細胞に
ついて白色化の程度を肉眼により比較した。
−3 試験結果
表4に結果を示す。[Table] *: High degree of whitening, +: Slight whitening, -: No whitening From the above results, the glucosamine derivative of the present invention significantly suppresses melanin production in pigment cells;
It was found that the effect was reversible and did not adversely affect cell growth. In contrast, with conventionally known hydroquinone, pigment cells remained white even in re-cultivation without the addition of a test solution, and cell growth was also extremely poor. Test Example 3 Two or more test substances of Test Example 1 were mixed and cultured according to the test method of Test Example 1, and the degree of whitening of the obtained cells was visually compared. -3 Test results Table 4 shows the results.
【表】【table】
【表】
※ :白色化度大、+:やや白色化、−:白色化せ
ず
以上の結果より、本発明のグルコサミン誘導体
は、1種または2種以上を用いても、その他の還
元性皮膚黒化防止物質を共に用いても、白色化効
果にはほとんど影響がないことが認められた。
試験例 4
年齢21〜61歳までの男性15名、女性15名、計30
名からなる被検者の上腕屈側部に、クローズドパ
ツチテストを実施した。試料としては試験例1の
試験物質の1%溶液を用いた。
判定の基準 −;全く無反応、±;軽微な紅斑、
+;明らかな紅斑、++;紅斑及び腫張、丘疹
−4 試験結果
表5−1および表5−2に結果を示す。[Table] *: Large degree of whitening, +: Slightly whitening, -: No whitening From the above results, the glucosamine derivative of the present invention has no effect on other reducing skin conditions even when one or more types are used. It was found that even when an anti-blackening substance was used together, the whitening effect was hardly affected. Test example 4 15 men and 15 women between the ages of 21 and 61, total 30
A closed patch test was performed on the flexor side of the upper arm of each subject. A 1% solution of the test substance of Test Example 1 was used as a sample. Judgment criteria -: No reaction at all, ±: Slight erythema,
+: Obvious erythema, ++: Erythema and swelling, papule-4 Test results The results are shown in Table 5-1 and Table 5-2.
【表】【table】
【表】【table】
次に本発明の実施例を示す。配合割合は重量部
である。
実施例1 皮膚用ローシヨン
ポリオキシエチレン
(20)モノオレート 1.0
エタノール 3.0
ポリエチレングリコール600 5.0
クエン酸 0.03
クエン酸ナトリウム 0.2
N−アセチル−1,3,4,6−テトラ−O−
プロピオニルグルコサミン 0.1
メチルパラベン 0.1
香料 適量
水 残余
実施例2 皮膚用パツク
ポリビニルアルコール 2
エタノール 20
N−ブチリル−1,3,4,6−テトラ−O−
ブチリルグリコサミン 1
N−オクタノイル−グルコサミン 1
グリセリン 5
香料 適量
水 残余
実施例3 外用クリーム
密ロウ 4.0
ステアリン酸 5.0
セタノール 5.0
ラノリン 3.0
プリスタン3.0
ポリオキシエチレン
スナアレート 3.5
グリセリンモノステアレート 1.5
N−オクチル−1,3,4,6−テトラ−O−
ナクチルグルコサミン 5.0
プロピレングリコール 10.0
香料.防腐剤 適量
水 残余
本発明の色白化粧料とアスコルビン酸、コウジ
酸、桂皮アルデヒド等皮膚の黒化を防止する物質
を配合した色白化粧料を用いて、健康な男性の上
腕部における色黒、シミ、ソバカスの防止の使用
テストを行なつたが、ここにおいても本発明の色
白化粧料の効果が格段に優れていることが実証さ
れた。
〔発明の効果〕
以上詳述した如く、本発明は皮膚の黒化を防止
する成分としてグルコサミン誘導体を効果的に配
合した色白化粧料に関するものであり、従来知ら
れている各種アスコルビン酸類、過酸化水素、グ
ルタチオン、コロイド硫黄、コウジ酸、桂皮アル
デヒド等の皮膚の黒化を防止する物質を配合した
色白化粧料と比べ、日光からの紫外線照射によつ
て生じる皮膚の黒化をはるかに防ぐことができ、
皮膚の色黒やシミ、ソバカスの防止、美肌作用等
の効果が優れていると共に、ハイドロキノンにみ
られるような細胞毒性が殆どないため白斑等の弊
害を起こす恐れがなく安全に用いることができる
ものである。
Next, examples of the present invention will be shown. The blending ratio is in parts by weight. Example 1 Skin lotion Polyoxyethylene (20) Monooleate 1.0 Ethanol 3.0 Polyethylene glycol 600 5.0 Citric acid 0.03 Sodium citrate 0.2 N-acetyl-1,3,4,6-tetra-O-
Propionylglucosamine 0.1 Methylparaben 0.1 Fragrance Appropriate amount Water Residual Example 2 Skin pack Polyvinyl alcohol 2 Ethanol 20 N-Butyryl-1,3,4,6-tetra-O-
Butyrylglycosamine 1 N-octanoyl-glucosamine 1 Glycerin 5 Fragrance Appropriate amount Water Remaining Example 3 Topical cream Beeswax 4.0 Stearic acid 5.0 Setanol 5.0 Lanolin 3.0 Pristane 3.0 Polyoxyethylene Sunaate 3.5 Glycerin monostearate 1.5 N-Octyl-1, 3,4,6-tetra-O-
Nactylglucosamine 5.0 Propylene glycol 10.0 Fragrance. Preservative Appropriate amount Water Residual Using the skin lightening cosmetic of the present invention and substances that prevent skin darkening such as ascorbic acid, kojic acid, and cinnamaldehyde, it is possible to prevent dark skin and spots on the upper arms of healthy men. , a use test was conducted to prevent freckles, and it was demonstrated that the fairing cosmetics of the present invention were extremely effective here as well. [Effects of the Invention] As detailed above, the present invention relates to a skin-lightening cosmetic that effectively contains a glucosamine derivative as an ingredient that prevents skin darkening. Compared to skin lightening cosmetics that contain substances that prevent skin darkening such as hydrogen, glutathione, colloidal sulfur, kojic acid, and cinnamaldehyde, this product is far more effective at preventing skin darkening caused by ultraviolet rays from sunlight. I can,
It has excellent effects such as preventing dark skin, age spots, and freckles, and beautifying the skin. It also has almost no cytotoxicity like hydroquinone, so it can be used safely without the risk of causing adverse effects such as vitiligo. It is.
Claims (1)
のアシル基を示す)で示されるグリコサミン誘導
体の内1種または2種以上を有効成分として配合
してなる色白化粧料。 2 グルコサミン誘導体の配合量が色白化粧料の
0.001〜10重量%である特許請求の範囲第1項記
載の色白化粧料。[Scope of Claims] 1 Formula [ Chemical formula ]
A fair-skinned cosmetic containing one or more of the glycosamine derivatives represented by the following acyl groups as an active ingredient. 2 The amount of glucosamine derivatives contained in fair skin cosmetics
The fair-skinned cosmetic according to claim 1, which contains 0.001 to 10% by weight.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP17735585A JPS6236306A (en) | 1985-08-12 | 1985-08-12 | Skin-beautifying cosmetic |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP17735585A JPS6236306A (en) | 1985-08-12 | 1985-08-12 | Skin-beautifying cosmetic |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6236306A JPS6236306A (en) | 1987-02-17 |
JPH0581566B2 true JPH0581566B2 (en) | 1993-11-15 |
Family
ID=16029516
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP17735585A Granted JPS6236306A (en) | 1985-08-12 | 1985-08-12 | Skin-beautifying cosmetic |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6236306A (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2565513B2 (en) * | 1987-09-25 | 1996-12-18 | 三省製薬株式会社 | Topical drug for suppressing melanin production |
JPH02262504A (en) * | 1988-12-24 | 1990-10-25 | Rinjiro Saruno | Inhibitor of melanin dyestuff formation |
JP2585094B2 (en) * | 1989-03-16 | 1997-02-26 | 株式会社 コーセー | Cosmetics |
JPH0311019A (en) * | 1989-06-08 | 1991-01-18 | Sansho Seiyaku Co Ltd | External preparation for inhibiting melanin formation |
KR940000166B1 (en) * | 1989-11-09 | 1994-01-08 | 니혼다바고 상교오 가부시기가이샤 | Novel glucosamine derivative and liposome containing the same as membrane component |
WO1991007416A1 (en) * | 1989-11-09 | 1991-05-30 | Japan Tobacco Inc. | Novel glucosamine derivative and liposome containing the same as membrane component |
KR940004071B1 (en) * | 1990-04-12 | 1994-05-11 | 니홍 다바꼬 상교 가부시끼가이샤 | 4,6-o-hydroxy phosphorylglucosamine derivatives |
WO2001001993A1 (en) * | 1999-07-02 | 2001-01-11 | Greither, Peter | A formulation of glucosamine sulphate |
EP1941863A3 (en) * | 2002-07-25 | 2008-12-31 | Lion Corporation | External preparation composition |
DE60225077D1 (en) | 2002-07-25 | 2008-03-27 | Lion Corp | TOPICAL PREPARATION |
CN101177438B (en) * | 2002-10-09 | 2012-05-23 | 花王株式会社 | N-acetylglucosamine derivatives and use thereof |
US7393937B2 (en) | 2002-10-09 | 2008-07-01 | Kao Corporation | N-acetylglucosamine derivatives and use thereof |
WO2005074879A1 (en) * | 2004-02-04 | 2005-08-18 | Kao Corporation | Wrinkle-diminishing agent |
EP2094277A4 (en) * | 2006-10-20 | 2010-01-20 | Kim Soo Youl | A composition for treatment of atopic dermatitis comprising glucosamine and derivatives thereof and a method for treatment of atopic dermatitis using them |
JP5258993B1 (en) * | 2012-03-29 | 2013-08-07 | 株式会社 資生堂 | Heparan sulfate production promoter |
US11241374B2 (en) * | 2018-06-28 | 2022-02-08 | Johnson & Johnson Consumer Inc. | Compositions and methods for treating skin conditions using light and glucosamine hydrochloride |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4920762A (en) * | 1972-06-20 | 1974-02-23 | ||
JPS5913708A (en) * | 1982-07-14 | 1984-01-24 | Shiseido Co Ltd | Cosmetic |
JPS59157009A (en) * | 1983-02-25 | 1984-09-06 | Yakurigaku Chuo Kenkyusho:Kk | External skin drug for suppressing formation of melanin |
-
1985
- 1985-08-12 JP JP17735585A patent/JPS6236306A/en active Granted
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4920762A (en) * | 1972-06-20 | 1974-02-23 | ||
JPS5913708A (en) * | 1982-07-14 | 1984-01-24 | Shiseido Co Ltd | Cosmetic |
JPS59157009A (en) * | 1983-02-25 | 1984-09-06 | Yakurigaku Chuo Kenkyusho:Kk | External skin drug for suppressing formation of melanin |
Also Published As
Publication number | Publication date |
---|---|
JPS6236306A (en) | 1987-02-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4025546B2 (en) | Skin beautifying agent, skin anti-aging agent, whitening agent and skin external preparation | |
JPH0581566B2 (en) | ||
JP4564471B2 (en) | Composition suitable for external use | |
US5601806A (en) | Methods for scavenging active oxygen compounds and preventing damage from ultra violet B rays using taurine analogues | |
JP2000095663A (en) | Agent for external use containing plant extract | |
EP0345082A2 (en) | Enzyme formation suppressing agent | |
JPS60202806A (en) | Whitening cosmetic | |
JPH05186324A (en) | Beautifying cosmetic | |
JPH05320039A (en) | Skin-beautifying cosmetic | |
KR100389983B1 (en) | Skin whitening composition containing arbutin and glucosidase as active ingredients | |
JPH03275613A (en) | Skin external agent | |
JP4906179B2 (en) | Topical skin preparation | |
JP2003137714A (en) | Cosmetic composition or pharmaceutical composition | |
JP2000344653A (en) | Eraser for active oxygen and skin cosmetic | |
CN114948789A (en) | SOD composition with high-efficiency blue light resisting effect and preparation method thereof | |
EP0345081A2 (en) | Enzyme formation suppressing agent | |
KR101305691B1 (en) | Anti-aging composition containing Cellulixir | |
JP4726505B2 (en) | External preparation for skin and skin whitening method | |
JP4610705B2 (en) | Topical skin preparation | |
JPH02273608A (en) | White colored cosmetic stock | |
JPH04187618A (en) | Skin external preparation | |
JPS6236307A (en) | Skin-beautifying cosmetic | |
JPH05509291A (en) | Phenylamine depigmentation, anti-melanoma agent | |
RU2096032C1 (en) | Cosmetic agent | |
JP4804729B2 (en) | Composition for improving peripheral blood circulation |